
China Approves First Gene Therapy for Hemophilia B in Major Medical Leap
China approves its first gene therapy for hemophilia B, BBM-H901, offering a potential long-term treatment for patients and advancing genomic medicine in Asia.
News & Insights Across Asia
China approves its first gene therapy for hemophilia B, BBM-H901, offering a potential long-term treatment for patients and advancing genomic medicine in Asia.
China’s mother-child care industry blends tradition with modern science as new generations embrace professional postpartum centers and evidence-based recovery methods.
Chinese researchers launch clinical trials for a groundbreaking mRNA tuberculosis vaccine, promising 20x higher efficacy than traditional options in early tests.
China’s sleep health industry skyrockets as clinics and tech innovations address rising disorders, reshaping wellness markets and public health strategies.
Chinese surgeons achieve milestone with first successful gene-edited pig kidney transplant, offering new hope for millions facing organ shortages.
Leading hepatologist Dr. Xia Qiang discusses how living donor liver transplants are revolutionizing pediatric care in China, offering hope for children with severe liver disease.
China releases BCI pricing guidelines, advancing clinical integration for paralysis treatment and neurotech innovation.
CGTN’s Ask China explores the affordability of medical care, universal healthcare access, and the role of traditional Chinese medicine in the mainland.
China’s healthcare system has transformed since the 1980s, achieving near-universal insurance coverage and world-class medical infrastructure through public-private collaboration and international partnerships.
With 1.9 billion projected to have obesity by 2035, global health systems face a $4 trillion challenge. China leads in numbers, with 600 million affected adults driving policy reforms.
Chinese scientist Wang Yongjun wins the prestigious Feinberg Award for his groundbreaking contributions to stroke research and treatment.